PubRank

SVF (Adipose Tissue Derived MSC) Based Therapy for CKD. (StemCell&CKD)

Clinical Trial ID NCT03939741

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT03939741

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Chronic kidney disease: global dimension and perspectives. Lancet 2013 8.16
2 Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004 6.90
3 'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis 2012 5.70
4 Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol 2007 3.60
5 Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev 2009 3.43
6 Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol 2005 2.79
7 Defining adipose tissue-derived stem cells in tissue and in culture. Histol Histopathol 2010 1.95
8 Adipose-derived stem and progenitor cells as fillers in plastic and reconstructive surgery. Plast Reconstr Surg 2006 1.76
9 IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury. Stem Cells 2008 1.75
10 Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model. Stem Cells 2009 1.71
11 Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study. Stem Cells Transl Med 2013 1.68
12 Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice. Biol Blood Marrow Transplant 2008 1.68
13 Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. J Transl Med 2009 1.62
14 A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments. PLoS Med 2012 1.47
15 Kidney regeneration. Lancet 2010 1.47
16 The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. J Am Coll Cardiol 2005 1.43
17 Adipose-derived stromal cells--their utility and potential in bone formation. Int J Obes Relat Metab Disord 2000 1.39
18 Adipose tissue-resident immune cells: key players in immunometabolism. Trends Endocrinol Metab 2012 1.36
19 Adipose-derived cells. Cell Transplant 2007 1.16
20 Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation. Nephrol Dial Transplant 2009 1.10
21 The potential of adipose-derived adult stem cells as a source of neuronal progenitor cells. Plast Reconstr Surg 2005 1.03
22 Which is the most suitable and effective route of administration for mesenchymal stem cell-based immunomodulation therapy in experimental kidney transplantation: endovenous or arterial? Transplant Proc 2010 1.02
23 Chronic kidney disease: a research and public health priority. Nephrol Dial Transplant 2012 1.01
24 Repeated administration of bone marrow-derived mesenchymal stem cells improved the protective effects on a remnant kidney model. Ren Fail 2010 1.01
25 Human mesenchymal stem cells derived from adipose tissue reduce functional and tissue damage in a rat model of chronic renal failure. Clin Sci (Lond) 2013 0.95
26 Mesenchymal stem cell treatment for chronic renal failure. Stem Cell Res Ther 2014 0.91
27 Safety and efficacy of intravenous infusion of allogeneic cryopreserved mesenchymal stem cells for treatment of chronic kidney disease in cats: results of three sequential pilot studies. Stem Cell Res Ther 2013 0.90
28 Novel therapies for FSGS: preclinical and clinical studies. Adv Chronic Kidney Dis 2015 0.84
29 Cell-based therapies for experimental chronic kidney disease: a systematic review and meta-analysis. Dis Model Mech 2015 0.84
30 Stromal progenitor cells present within liposuction and reduction abdominoplasty fat for autologous transfer to aged skin. Dermatol Surg 1999 0.84
31 Mesenchymal Stem Cell-Based Therapy for Kidney Disease: A Review of Clinical Evidence. Stem Cells Int 2016 0.83
32 Repeated systemic administration of human adipose-derived stem cells attenuates overt diabetic nephropathy in rats. Stem Cells Dev 2013 0.83
33 Adipose tissue-derived mesenchymal stem cells: a fat chance of curing kidney disease? Kidney Int 2012 0.81
34 Update on the management of chronic kidney disease. Am Fam Physician 2012 0.80
35 Comparative analysis of periprostatic implantation and intracavernosal injection of human adipose tissue-derived stem cells for erectile function recovery in a rat model of cavernous nerve injury. Prostate 2012 0.79
Next 100